GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Shiller PE Ratio

Theratechnologies (Theratechnologies) Shiller PE Ratio : (As of Jun. 10, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Theratechnologies Shiller PE Ratio Historical Data

The historical data trend for Theratechnologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Shiller PE Ratio Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Theratechnologies Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Theratechnologies's Shiller PE Ratio

For the Biotechnology subindustry, Theratechnologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theratechnologies's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theratechnologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Theratechnologies's Shiller PE Ratio falls into.



Theratechnologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Theratechnologies's E10 for the quarter that ended in Feb. 2024 is calculated as:

For example, Theratechnologies's adjusted earnings per share data for the three months ended in Feb. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=-0.1/125.4675*125.4675
=-0.100

Current CPI (Feb. 2024) = 125.4675.

Theratechnologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201405 0.074 99.394 0.093
201408 -0.258 99.315 -0.326
201411 -0.189 99.078 -0.239
201502 -0.032 99.078 -0.041
201505 0.032 100.263 0.040
201508 0.060 100.579 0.075
201511 -0.001 100.421 -0.001
201602 -0.007 100.421 -0.009
201605 -0.031 101.765 -0.038
201608 0.031 101.686 0.038
201611 0.019 101.607 0.023
201702 -0.091 102.476 -0.111
201705 -0.356 103.108 -0.433
201708 -0.127 103.108 -0.155
201711 -0.143 103.740 -0.173
201802 -0.120 104.688 -0.144
201805 -0.120 105.399 -0.143
201808 0.014 106.031 0.017
201811 -0.040 105.478 -0.048
201902 -0.080 106.268 -0.094
201905 -0.160 107.927 -0.186
201908 -0.080 108.085 -0.093
201911 -0.320 107.769 -0.373
202002 -0.240 108.559 -0.277
202005 -0.320 107.532 -0.373
202008 -0.360 108.243 -0.417
202011 -0.280 108.796 -0.323
202102 -0.280 109.745 -0.320
202105 -0.280 111.404 -0.315
202108 -0.400 112.668 -0.445
202111 -0.410 113.932 -0.452
202202 -0.360 115.986 -0.389
202205 -0.960 120.016 -1.004
202208 -0.320 120.569 -0.333
202211 -0.330 121.675 -0.340
202302 -0.432 122.070 -0.444
202305 -0.400 124.045 -0.405
202308 -0.030 125.389 -0.030
202311 -0.030 125.468 -0.030
202402 -0.100 125.468 -0.100

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Theratechnologies  (NAS:THTX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Theratechnologies Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Theratechnologies (Theratechnologies) Business Description

Traded in Other Exchanges
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.